Are we ready to escalate or de-escalate immune treatment strategies in NSCLC based on liquid biopsy data?

Jordi Remon, Alvaro Lopez, David Planchard, Benjamin Besse

    Research output: Contribution to journalEditorial

    Original languageEnglish
    Article number113369
    JournalEuropean Journal of Cancer
    Volume195
    DOIs
    Publication statusPublished - 1 Dec 2023

    Keywords

    • Ct-DNA
    • Immune checkpoint blockers
    • Liquid biopsy
    • Non-small cell lung cancer

    Cite this